Trendex vs MarketAxess
Side-by-side comparison of AI visibility scores, market position, and capabilities
Sports betting analytics platform with statistical models and matchup analysis; player props, injury news, and betting line tracking for recreational bettors in the expanding US sports wagering market.
About
Trendex is a sports betting and fantasy sports analytics platform providing statistical modeling, injury news, matchup analysis, and data-driven betting insights for recreational and serious sports bettors across football, basketball, baseball, and soccer — delivering content through a mobile app and website in the rapidly expanding US sports betting market following the 2018 PASPA Supreme Court ruling that legalized sports betting nationwide. Founded in 2021 and headquartered in the United States, Trendex targets sports fans who want data-driven edge in their sports betting and daily fantasy sports (DFS) decisions.\n\nTrendex aggregates player statistics, team performance metrics, injury reports, weather conditions, betting lines from major sportsbooks, and historical matchup data into predictive models that surface betting edges and player prop value for daily fantasy contests. The platform provides projected stats, injury probability, betting line movement analysis, and community picks from expert analysts. The mobile experience is designed for in-game consumption — checking player stats and injury news during live games.\n\nIn 2025, Trendex operates in the sports analytics and betting media market alongside established players like The Action Network (Chernin Group), DraftKings Rotogrinders, RotoWire, and ESPN Bet Insider for sports betting information. The US sports betting market has grown dramatically since legalization — approximately 30 states have legalized sports wagering — creating large consumer demand for actionable betting information. Trendex competes for user attention against free tools embedded in sportsbook apps (DraftKings, FanDuel, BetMGM all provide analytics within their apps) and established sports media brands. The 2025 strategy focuses on growing its subscriber base, adding more AI-powered predictive features, and expanding into additional sports leagues and international markets.
New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.
About
MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.